QM
Qiming Managing Directors Fund V, L.P. cut its CNTB stake below 5%
Qiming Managing Directors Fund V, L.P. reported owning 2.9% of Connect Biopharma Holdings Ltd (CNTB) (1,821,426 shares) in a Schedule 13G filed Nov 4, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 4, 2026
- Source
- Schedule 13G